Japan Lifeline achieved sales of \u00a515.9 billion (up 8.8% YoY) in the first quarter of FY2027, with net profit of \u00a5230 million (almost flat). The company recorded record highs driven by new products and overseas expansion, despite a decrease in operating profit due to increased R&D expenses.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7575","jir_company_name":"Japan Lifeline Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-07-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/7575-20260730-01.pdf","jir_short_summary":"Japan Lifeline achieved sales of \u00a515.9 billion (up 8.8% YoY) in the first quarter of FY2027, with net profit of \u00a5230 million (almost flat). The company recorded record highs driven by new products and overseas expansion, despite a decrease in operating profit due to increased R&D expenses.","jir_summary":"### Performance Overview\nJapan Lifeline recorded sales of \u00a515.9 billion (up 8.8% YoY) in the first quarter of FY2027, reaching an all-time high. Growth was driven by expanded sales of new products and expansion into overseas markets, while operating profit declined due to increased R&D expenses. Net income remained relatively unchanged, indicating a stable revenue base. The expanding demand for medical devices and entry into new areas are key to future growth.\n\n### Outlook and Shareholder Impact\nThe company maintains its full-year earnings forecast for FY2027 and has revised its dividend outlook to an interim dividend of 25 yen and a year-end dividend of 56 yen, totaling 81 yen. It aims to expand sales through overseas development and new product launches, while continuing to invest in R&D for long-term growth. The company plans to increase dividends as a shareholder return measure, responding to investor expectations.","jir_financial_highlights":"Sales: \u00a515.9 billion (up 8.8% YoY)\nNet income attributable to owners of parent: \u00a5230 million (almost flat)\nOperating profit: \u00a52.97 billion (down 9.4% YoY)","jir_category":"","jir_hashtags":"#JapanLifeline, #IRFinancialResults, #JapaneseStocks","jir_key_figures":"Sales: \u00a515.9 billion (up 8.8% YoY)\nNet income attributable to owners of parent: \u00a5230 million (almost flat)\nOperating profit: \u00a52.97 billion (down 9.4% YoY)","jir_meta_title":"\u3010Japan Lifeline\u3011Q1 FY2027 Earnings\uff5cSales of \u00a515.9 billion (up 8.8%)","jir_meta_description":"Japan Lifeline achieved sales of \u00a515.9 billion (up 8.8% YoY) in the first quarter of FY2027, setting a record high. Net profit was \u00a5230 million, remaining flat. An overview of future growth prospects and dividend policies is also provided.","jir_og_title":"\u3010Japan Lifeline\u3011Q1 FY2027 Earnings\uff5cSales of \u00a515.9 billion (up 8.8%)","jir_og_description":"Japan Lifeline's Q1 FY2027 results show sales of \u00a515.9 billion and net profit of \u00a5230 million. Future outlook and dividend forecasts are also detailed.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9484,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-90898","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n